Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient vaginal misoprostol plus membrane stripping for post-term pregnancy induction in primigravida women
IRCT20180215038742N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol in Pregnancy prolongation (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Delivery rate before 41 weeks of gestational age, Interval from admission time to second stage of labor and 7 more. Started Apr 2018; status: completed.
02
Drugs
misoprostol
03
Conditions
Pregnancy prolongation
Beyond the preview
Go deeper on IRCT20180215038742N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180215038742N1.